Showing results (781-790 of 4,776) with videos related to

Sort By:
Pageof 478
Health Policy (Amsterdam, Netherlands)|July 28, 2005
Social capital and farmer's willingness-to-join a newly established community-based health insurance in rural ChinaLicheng Zhang, Hong Wang, Lushang Wang, et al.
Health Policy (Amsterdam, Netherlands)|August 6, 2005
Priority setting for horizon scanning of new health technologies in Denmark: views of health care stakeholders and health economistsKarla Douw, Hindrik Vondeling, Wija Oortwijn
Health Policy (Amsterdam, Netherlands)|May 9, 2006
Exploring the human resource implications of clinical governanceChandra Vanu Som
Health Policy (Amsterdam, Netherlands)|May 9, 2006
Resource allocation in public hospitals: is it effective?Nimnath Withanachchi, Yasuo Uchida, Shyama Nanayakkara, et al.
Health Policy (Amsterdam, Netherlands)|June 18, 2010
Self-rated health status transition and long-term care need, of the oldest ChineseRong Peng, Li Ling, Qun He
Health Policy (Amsterdam, Netherlands)|June 19, 2010
How much of the income inequality effect can be explained by public policy? Evidence from oral health in BrazilRoger Keller Celeste, Paulo Nadanovsky
Health Policy (Amsterdam, Netherlands)|September 11, 2010
Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health SurveyAnita K Wagner, Amy Johnson Graves, Sheila K Reiss, et al.
Health Policy (Amsterdam, Netherlands)|October 5, 2010
Patient affiliation with GPs in Australia--who is and who is not and does it matter?Ian McRae, Laurann Yen, James Gillespie, et al.
Health Policy (Amsterdam, Netherlands)|July 27, 2010
A randomized experiment of issue framing and voter support of tax increases for health insurance expansionHector P Rodriguez, Miriam J Laugesen, Carolyn A Watts
Health Policy (Amsterdam, Netherlands)|July 10, 2010
Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern UgandaLubega Muhamadi, Xavier Nsabagasani, Mbona Nazarius Tumwesigye, et al.
Pageof 478